PFND Stock Price, Chart, Stats & News

Pathfinder Cell Therapy, Inc.
Save
Pathfinder Cell Therapy, Inc. (PFND) does not currently pay a dividend.
66,716
Market cap
–
Current P/E
–
Forward P/E
PFND chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others.
Similar securities
Based on sector and market capitalization
Report issue





